Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
As with most medical breakthroughs, the development and implementation of GLP-1 RA drugs is not straightforward
Once the target dose is identified, we intend to study an implant at that dose over the full 6-month duration, over which our implant has already demonstrated encouraging results in preclinical animal models
These medications activate GLP-1 receptors in the brain and pancreas, regulating appetite, glucose secretion, and metabolic function
Furthermore, in a 12-week trial, semaglutide was shown to reduce body weight predominantly through appetite suppression, but this effect was also accompanied by a marked reduction in preference for high-fat foods (Blundell et al., 2017)
16 if separate vials
US$ 26.17
US$ 28.83
US$ 23.47
US$ 21.05
US$ 26.30
US$ 23.21
US$ 21.24
